Key Documents
Elizabeth Alli
Academic Appointments
- Postdoctoral Research fellow, School of Medicine
Contact Information
- Academic
Offices
Personal Information Email
Professional Snapshot
Honors and Awards
- Postdoctoral Fellowship, Susan G. Komen for the Cure (2008-2011)
- Scholar-in-Training Award, AACR-Bristol-Myers Squibb Oncology (2008)
- Travel Fellowship, Anna Henzl Gabor Young Women in Science Fund (2007)
- Deans Postdoctoral Fellowship, Stanford University-School of Medicine (2007)
- Scholar-in-Training Award, AACR-Merck (2005)
Professional Education
| Doctor of Philosophy: | University of Medicine and Dentistry, (2005) |
Faculty Advisor
Web Site Links
Scientific Focus
Research Interests
I am interested in identifying targeted therapies for triple-negative breast cancers and developing a novel strategy of biomarker-based chemoprevention for hereditary cancers that arise due to mutations in the Breast Cancer Susceptibility Gene 1 (BRCA1).
Publications
- Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase. Cancer Res. 2009; (8): 3589-96
- Silencing of stathmin induces tumor-suppressor function in breast cancer cell lines harboring mutant p53. Oncogene. 2007; (7): 1003-12
- Reversal of stathmin-mediated resistance to paclitaxel and vinblastine in human breast carcinoma cells. Mol Pharmacol. 2007; (5): 1233-40
- Tubulin Targeting Agents Update on Cancer Therapeutics. 2006; (1): 1-18
- A Phase I/pilot study of sequential doxorubicin/vinorelbine: effects on p53 and microtubule-associated protein 4. Clin Cancer Res. 2002; (5): 1057-64
Help
Trial Administration